PubRank

Pablo C Okhuysen

Author PubWeight™ 60.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008 2.79
2 A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005 2.58
3 Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 2007 2.37
4 A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol 2006 1.54
5 A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect Immun 2008 1.47
6 Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med 2014 1.47
7 Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med 2014 1.43
8 Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis 2006 1.38
9 Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 2006 1.35
10 Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 2003 1.30
11 HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep 2002 1.25
12 A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone. Pharmacotherapy 2005 1.18
13 Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol 2004 1.18
14 Cryptosporidiosis. Curr Opin Infect Dis 2002 1.17
15 Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol 2009 1.14
16 Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol 2006 1.09
17 A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis 2007 1.09
18 Molecular epidemiology of the fsr locus and of gelatinase production among different subsets of Enterococcus faecalis isolates. J Clin Microbiol 2004 1.06
19 Cryptosporidiosis in children. Semin Pediatr Infect Dis 2004 1.05
20 Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol 2005 1.03
21 Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. J Med Microbiol 2007 1.03
22 Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol 2004 1.02
23 Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hyg 2003 1.01
24 Enteropathogens and chronic illness in returning travelers. N Engl J Med 2013 0.99
25 Cryptosporidium dose-response studies: variation between hosts. Risk Anal 2002 0.99
26 PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea. J Clin Microbiol 2008 0.95
27 Enteroaggregative Escherichia coli (EAEC): a cause of acute and persistent diarrhea of worldwide importance. J Infect Dis 2010 0.93
28 Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A 2013 0.93
29 Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol 2008 0.93
30 Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med 2008 0.92
31 Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol 2010 0.92
32 Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis 2011 0.90
33 Rifaximin treatment of pathogen-negative travelers' diarrhea. J Travel Med 2007 0.90
34 Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses. J Med Virol 2006 0.90
35 Cryptosporidium meleagridis: infectivity in healthy adult volunteers. Am J Trop Med Hyg 2011 0.89
36 Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med 2007 0.89
37 Genetics of susceptibility to infection with enteric pathogens. Curr Opin Infect Dis 2009 0.86
38 Cryptosporidium muris in a Texas canine population. Am J Trop Med Hyg 2008 0.85
39 Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study. J Med Microbiol 2008 0.85
40 Cryptosporidium dose response studies: variation between isolates. Risk Anal 2002 0.85
41 Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis 2011 0.85
42 Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med 2011 0.84
43 Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med 2010 0.82
44 Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007. J Infect Dis 2010 0.82
45 High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity. Infect Immun 2006 0.82
46 A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season. J Travel Med 2011 0.82
47 A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. J Infect Dis 2009 0.81
48 Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg 2008 0.81
49 Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis 2003 0.81
50 Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae. J Parasitol 2002 0.79
51 Evaluation of recombinant oocyst protein CP41 for detection of cryptosporidium-specific antibodies. Clin Diagn Lab Immunol 2005 0.78
52 Cryptosporidium parvum: identification and characterization of an acid phosphatase. Parasitol Res 2007 0.78
53 Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis 2005 0.78
54 Human studies provide insight into the pathogenesis, immunology, and treatment of cryptosporidiosis. Clin Infect Dis 2003 0.77
55 Molecular cloning and analysis of the Cryptosporidium parvum aminopeptidase N gene. Int J Parasitol 2002 0.76
56 Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea. Clin Vaccine Immunol 2010 0.75
57 Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med 2010 0.75
58 Treatment of chronic cryptosporidiosis in AIDS with rIL-12 induces an immune response associated with improvement but severe side-effects. AIDS 2005 0.75